Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
ESMO Open
.
2018 Jun 20;3(4):e000404.
doi: 10.1136/esmoopen-2018-000404.
eCollection 2018.
Authors
Marco C Merlano
1
,
Ornella Garrone
1
Affiliation
1
Oncology Department, S. Croce and Carle Teaching Hospital, Cuneo, Italy.
PMID:
29942669
PMCID:
PMC6012560
DOI:
10.1136/esmoopen-2018-000404
No abstract available
Keywords:
head and neck cancer.
Publication types
Editorial